IMV Corporation

Equities

7760

JP3100760002

Industrial Machinery & Equipment

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
626 JPY -0.16% Intraday chart for IMV Corporation +4.51% +20.15%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023. CI
BioVaxys Technology Plans Private Placement; Down 5.9% MT
Biovaxys Completes The Acquisition Of All Intellectual Property And Clinical Stage Assets Of The Former IMV Inc. MT
BioVaxys Acquires Entire Technology Portfolio Of The Former IMV Inc. MT
Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023. CI
IMV Corporation announces an Equity Buyback for 400,000 shares, representing 2.45% for ¥250 million. CI
IMV Corporation authorizes a Buyback Plan. CI
IMV Corporation Reports Earnings Results for the Full Year Ended September 30, 2023 CI
EKF Diagnostics hires CFO from Trellus Health, latter names successor AN
Trellus Health's Interim Finance Head Takes Full-time CFO Role at EKF Diagnostics MT
Imv Corporation Provides Dividend Guidance for the Fiscal Year Ending September 30, 2023 CI
Imv Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2023 CI
IMV Corporation Reports Earnings Results for the Half Year Ended March 31, 2023 CI
IMV Receives Delisting Notice From Nasdaq Over Bankruptcy Proceedings in Canada MT
IMV Inc. Brief: Says Received NASDAQ Delisting Notice MT
IMV Inc. Brief: Says Received Nasdaq Notification Regarding Minimum Bid Price Deficiency MT
IMV Inc. Details Board Changes MT
IMV Inc. Brief: Hall Adds Co engaged Stonegate to explore strategic alternatives, "So that MVP-S can realize its full clinical potential" MT
IMV Inc. Brief: Andrew Hall, Chief Executive Officer, Said" "The market headwinds limiting available capital are, however, very real" MT
IMV Inc. Brief: Net loss and comprehensive loss of US$38.0 million ($4.55 per share) for Year ended December 31, 2022, Vs net loss and comprehensive loss of $36.6 ($4.93 per share) for Year ended December 31, 2021 MT
IMV Inc. Brief: As of December 31, 2022, Co had cash and cash equivalents of US$21.2 million and working capital of $18.2 million, compared to $38.6 million and $37.1 million, respectively on December 31, 2021 MT
IMV Inc. Brief: Says Has engaged Stonegate Healthcare Partners, L.L.C to explore strategic alternatives following a review of its business MT
North American Morning Briefing : Some Calm -2- DJ
Interstellar Technologies Inc. announced that it has received ¥3.8 billion in funding from a group of investors CI
IMV Inc. Announces Planned 2023 Milestones to Advance Clinical Development of Lead Therapeutic, MVP-S MT
Chart IMV Corporation
More charts
IMV CORPORATION is a Japan-based company mainly engaged in manufacturing and sales of dynamic simulation systems and measuring systems, as well as the operation of contracted vibration tests. The dynamic simulation system division is engaged in the manufacturing, sales, repair and maintenance of dynamic simulation systems and all-weather simulation systems. The test and solution service division is engaged in manufacturing and sales of dynamic simulation systems and all-weather simulation systems, as well as provision of measuring analysis service and other consulting service for vibration (environment) tests. The measuring systems division is engaged in manufacturing, sales, repair and maintenance of measuring systems, including vibration measuring system, vibration monitoring system, seismic monitoring system, environmental evaluation system and related equipment.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 7760 Stock
  4. News IMV Corporation
  5. BioVaxys Technology Plans Private Placement; Down 5.9%